Log In
Print
BCIQ
Print
Print this Print this
 

gandotinib (LY2784544)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSmall molecule Janus kinase-2 (JAK-2) inhibitor
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today